Works matching IS 13406868 AND DT 2024 AND VI 31 AND IP 3


Results: 21
    1
    2
    3
    4
    5
    6
    7
    8
    9

    The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment.

    Published in:
    Breast Cancer (13406868), 2024, v. 31, n. 3, p. 340, doi. 10.1007/s12282-024-01566-6
    By:
    • Yamamoto, Yutaka;
    • Yamauchi, Chikako;
    • Toyama, Tatsuya;
    • Nagai, Shigenori;
    • Sakai, Takehiko;
    • Kutomi, Goro;
    • Yoshimura, Michio;
    • Kawai, Masaaki;
    • Ohtani, Shoichiro;
    • Kubota, Kazunori;
    • Nakashima, Kazutaka;
    • Honma, Naoko;
    • Yoshida, Masayuki;
    • Tokunaga, Eriko;
    • Taira, Naruto;
    • Iwata, Hiroji;
    • Saji, Shigehira
    Publication type:
    Article
    10
    11
    12
    13

    Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines.

    Published in:
    Breast Cancer (13406868), 2024, v. 31, n. 3, p. 335, doi. 10.1007/s12282-024-01550-0
    By:
    • Hattori, Masaya;
    • Honma, Naoko;
    • Nagai, Shigenori;
    • Narui, Kazutaka;
    • Shigechi, Tomoko;
    • Ozaki, Yukinori;
    • Yoshida, Masayuki;
    • Sakatani, Takashi;
    • Sasaki, Eiichi;
    • Tanabe, Yuko;
    • Tsurutani, Junji;
    • Takano, Toshimi;
    • Saji, Shigehira;
    • Masuda, Shinobu;
    • Horii, Rie;
    • Tsuda, Hitoshi;
    • Yamaguchi, Rin;
    • Toyama, Tatsuya;
    • Yamauchi, Chikako;
    • Toi, Masakazu
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21